REPORT ID 6389

Global ENG(Endoglin precursor) Market Research Report 2017

Publish Date
26-Dec-17
Pages
125
Format
Electronic (PDF)

In this report, the global ENG(Endoglin precursor) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENG(Endoglin precursor) in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global ENG(Endoglin precursor) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Aviva Systems Biology Corporation(USA)
    Atlas Antibodies(Sweden)
    Abbexa Ltd(UK)
    Abiocode(US)
    Boster Biological Technology(USA)
    Biobyt(UK)
    Bio-Rad(US)
    Bioss Antibodies(US)
    Biosensis(US)
    BioLegend(US)
    BioVision(US)
    BethylLaboratories(US)
    Epigentek(US)
    EnzoLifeSciences(Switzerland)
    Genetex(US)
    Lifespan Biosciences(US)
    Novus Biologicals(US)
    Proteintech(US)
    ProSci(US)
    ProteoGenix(France)
    R&D Systems(US)
    Rockland(US)
    St John's Laboratory Ltd(UK)
    Stemcell(Canada)
    Thermo Fisher Scientific(US)
    USBiological(US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Above 90%
    Above 95%
    Above 99%
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Biopharmaceutical Companies
    Hospitals
    Bioscience Research Institutions
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global ENG(Endoglin precursor) Market Research Report 2017
1 ENG(Endoglin precursor) Market Overview
    1.1 Product Overview and Scope of ENG(Endoglin precursor)
    1.2 ENG(Endoglin precursor) Segment by Type (Product Category)
        1.2.1 Global ENG(Endoglin precursor) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global ENG(Endoglin precursor) Production Market Share by Type (Product Category) in 2016
        1.2.3 Above 90%
        1.2.4 Above 95%
        1.2.5 Above 99%
        1.2.6 Others
    1.3 Global ENG(Endoglin precursor) Segment by Application
        1.3.1 ENG(Endoglin precursor) Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Biopharmaceutical Companies
        1.3.3 Hospitals
        1.3.4 Bioscience Research Institutions
        1.3.5 Others
    1.4 Global ENG(Endoglin precursor) Market by Region (2012-2022)
        1.4.1 Global ENG(Endoglin precursor) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of ENG(Endoglin precursor) (2012-2022)
        1.5.1 Global ENG(Endoglin precursor) Revenue Status and Outlook (2012-2022)
        1.5.2 Global ENG(Endoglin precursor) Capacity, Production Status and Outlook (2012-2022)

2 Global ENG(Endoglin precursor) Market Competition by Manufacturers
    2.1 Global ENG(Endoglin precursor) Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global ENG(Endoglin precursor) Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global ENG(Endoglin precursor) Production and Share by Manufacturers (2012-2017)
    2.2 Global ENG(Endoglin precursor) Revenue and Share by Manufacturers (2012-2017)
    2.3 Global ENG(Endoglin precursor) Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers ENG(Endoglin precursor) Manufacturing Base Distribution, Sales Area and Product Type
    2.5 ENG(Endoglin precursor) Market Competitive Situation and Trends
        2.5.1 ENG(Endoglin precursor) Market Concentration Rate
        2.5.2 ENG(Endoglin precursor) Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global ENG(Endoglin precursor) Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global ENG(Endoglin precursor) Capacity and Market Share by Region (2012-2017)
    3.2 Global ENG(Endoglin precursor) Production and Market Share by Region (2012-2017)
    3.3 Global ENG(Endoglin precursor) Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global ENG(Endoglin precursor) Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global ENG(Endoglin precursor) Consumption by Region (2012-2017)
    4.2 North America ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)
    4.3 Europe ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)
    4.4 China ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)
    4.5 Japan ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)
    4.7 India ENG(Endoglin precursor) Production, Consumption, Export, Import (2012-2017)

5 Global ENG(Endoglin precursor) Production, Revenue (Value), Price Trend by Type
    5.1 Global ENG(Endoglin precursor) Production and Market Share by Type (2012-2017)
    5.2 Global ENG(Endoglin precursor) Revenue and Market Share by Type (2012-2017)
    5.3 Global ENG(Endoglin precursor) Price by Type (2012-2017)
    5.4 Global ENG(Endoglin precursor) Production Growth by Type (2012-2017)

6 Global ENG(Endoglin precursor) Market Analysis by Application
    6.1 Global ENG(Endoglin precursor) Consumption and Market Share by Application (2012-2017)
    6.2 Global ENG(Endoglin precursor) Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global ENG(Endoglin precursor) Manufacturers Profiles/Analysis
    7.1 Aviva Systems Biology Corporation(USA)
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Atlas Antibodies(Sweden)
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Atlas Antibodies(Sweden) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Abbexa Ltd(UK)
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Abbexa Ltd(UK) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Abiocode(US)
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Abiocode(US) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Boster Biological Technology(USA)
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Boster Biological Technology(USA) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Biobyt(UK)
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Biobyt(UK) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Bio-Rad(US)
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Bio-Rad(US) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Bioss Antibodies(US)
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Bioss Antibodies(US) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Biosensis(US)
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Biosensis(US) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 BioLegend(US)
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 ENG(Endoglin precursor) Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 BioLegend(US) ENG(Endoglin precursor) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 BioVision(US)
    7.12 BethylLaboratories(US)
    7.13 Epigentek(US)
    7.14 EnzoLifeSciences(Switzerland)
    7.15 Genetex(US)
    7.16 Lifespan Biosciences(US)
    7.17 Novus Biologicals(US)
    7.18 Proteintech(US)
    7.19 ProSci(US)
    7.20 ProteoGenix(France)
    7.21 R&D Systems(US)
    7.22 Rockland(US)
    7.23 St John's Laboratory Ltd(UK)
    7.24 Stemcell(Canada)
    7.25 Thermo Fisher Scientific(US)
    7.26 USBiological(US)

8 ENG(Endoglin precursor) Manufacturing Cost Analysis
    8.1 ENG(Endoglin precursor) Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of ENG(Endoglin precursor)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 ENG(Endoglin precursor) Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of ENG(Endoglin precursor) Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global ENG(Endoglin precursor) Market Forecast (2017-2022)
    12.1 Global ENG(Endoglin precursor) Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global ENG(Endoglin precursor) Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global ENG(Endoglin precursor) Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global ENG(Endoglin precursor) Price and Trend Forecast (2017-2022)
    12.2 Global ENG(Endoglin precursor) Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India ENG(Endoglin precursor) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global ENG(Endoglin precursor) Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global ENG(Endoglin precursor) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer